scholarly journals In vitro Evaluation of Antiproliferative, Lipoxygenase and Xanthine Oxidase Inhibitory Activities of Artemisia nilagirica (C.B.Clarke) Pamp. Leaf Extracts

2019 ◽  
Vol 81 (2) ◽  
Author(s):  
M. Y Bhat ◽  
M. Z Gul ◽  
M. K Husain ◽  
I. A Ghazi
2022 ◽  
pp. 100539
Author(s):  
Alex Laux ◽  
Josias Hamman ◽  
Hanna Svitina ◽  
Krzysztof Wrzesinski ◽  
Chrisna Gouws

2010 ◽  
Vol 13 (8) ◽  
pp. 362-368 ◽  
Author(s):  
N.T.R. Meda ◽  
A. Lamien-Med ◽  
M. Kiendrebeo ◽  
C.E. Lamien ◽  
A.Y. Coulibaly ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-13 ◽  
Author(s):  
Franklyn Nonso Iheagwam ◽  
Emmanuel Nsedu Israel ◽  
Kazeem Oyindamola Kayode ◽  
Opeyemi Christianah DeCampos ◽  
Olubanke Olujoke Ogunlana ◽  
...  

This study was carried out to assess the in vitro antioxidant, anti-inflammatory and antidiabetic effects of Nauclea latifolia (Sm.) leaf extracts. Ethanolic (NLE) and aqueous (NLA) extract of N. latifolia leaves were prepared and assessed for their anti-inflammatory activity, antioxidant potential, α-amylase and α-glucosidase inhibitory activities, and the mechanism of enzyme inhibition in vitro using standard established methods. From the results, phytochemicals such as flavonoids, phenolics, glycosides, and tannins were detected in both extracts of N. latifolia with NLE having a significantly (p<0.05) higher phytochemical content. NLE displayed significantly (p<0.05) better total antioxidant capacity, reducing power, 2,2-diphenyl-2-picrylhydrazyl, and hydrogen peroxide radical scavenging activities. For anti-inflammatory activities, 70.54±2.45% albumin denaturation inhibition was observed for NLE while 68.05±1.03% was recorded for NLA. Likewise, 16.07±1.60 and 14.08±1.76% were obtained against hypotonic solution and heat-induced erythrocyte haemolysis, respectively, for NLE while 20.59±4.60 and 24.07±1.60% were respective NLA values. NLE (IC50: 4.20±0.18 and 1.19±0.11 mg/mL) and NLA (IC50: 11.21±0.35 and 2.64±0.48 mg/mL) α-glucosidase and α-amylase inhibitory activities were dose-dependent with uncompetitive and competitive inhibition elicited, respectively, by the extracts. A significant positive association (p<0.01 and 0.05) was identified between antioxidant activity and carbohydrate-metabolising enzyme inhibitory activity. The obtained result suggests N. latifolia leaf could serve as an alternative candidate for managing diabetes mellitus due to its antioxidant and anti-inflammatory association with diabetes-linked enzymes.


Author(s):  
Karthikeyan Sekar ◽  
Rajeswary Hari ◽  
P. Ramya ◽  
N. Pusphavalli ◽  
R. Savitha

In the present investigation an attempt was made to evaluate the in vitro and in silico anti-gout arthritic activity of ethanolic (EECF) and aqueous extracts (AECF) of leaves of Cadaba fruticosa. The in vitro anti-gout arthritic activity of EECF and AECF was evaluated in terms of their inhibitory potential of xanthine oxidase, proteinase enzymes as well as protein denaturation and membrane stabilization using standard protocols. For the analysis of in silico anti-gout arthritic activity, molecular docking was performed for the GC–Ms derived 15 phyto constituents using patch dock server to find a suitable antagonistic ligand for the enzymes cyclooxygenase I and matrix metalloproteinase IV since they are the key enzymes responsible for pain and degenerative changes. Among the EECF and AECF extracts the EECF extract exhibited higher inhibitory activity of the xanthine oxidase and proteinase enzyme. At the concentrations of 800 and 1000μg/ml the observed inhibitory activity was almost similar to the positive drug Allopurinol and Acetyl salicylic acid. Based on the docking score and activation energy the two phyto constituents Quercetin and Cadabicinediacetate inhibited the enzymes cyclooxygenase I and matrix metalloproteinase IV and serves as a better antagonistic ligand to suppress the pain and joint destruction. It may be concluded that the leaves of Cadaba fruticosa may further developed into a effective drug for the management of gouty arthritis due to its multi targeted inhibitory activity of several inflammatory mediators.


2008 ◽  
Vol 157 (1-2) ◽  
pp. 1-8 ◽  
Author(s):  
Aya Matsuu ◽  
Masahiro Yamasaki ◽  
Xuenan Xuan ◽  
Hiromi Ikadai ◽  
Yoshiaki Hikasa

2020 ◽  
Vol 29 ◽  
pp. 101834
Author(s):  
Nadia Djermane ◽  
Lynda Gali ◽  
Rabah Arhab ◽  
Noureddine Gherraf ◽  
Chawki Bensouici ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document